UCI MIND Re-Designated as Alzheimer’s Disease Research Center
UCI MIND received a prestigious renewal designation as one of 27 Alzheimer’s Disease Research Centers in the nation by the National Institutes of Health (NIH). The renewal designation for UCI’s Alzheimer’s Disease Research Center (ADRC), a major center grant as a part of UC MIND, means the NIH will fund the center for another five years of Alzheimer’s disease research and education.
The NIH funds the most promising research centers at major medical institutions across the United States. As an ADRC, UCI MIND is part of an elite network of researchers with a broad scope of expertise, spanning many different disciplines. This opportunity for collaboration allows researchers around the country to share cutting-edge ideas and research results.
UCI MIND’s ADRC features a multidisciplinary team working to provide a comprehensive approach to research and care through these core components: Clinical, Neuropathology, Education and Information, Data and Statistical Management and Administrative.
The UCI ADRC was established in 1985 in partnership with USC under former director Professor Carl Cotman, Neurobiology and Behavior. In 2000, the UCI ADRC was designated as an independent center to grow the research enterprise, capitalize on our strengths, and better position UCI to address the growing number of people with Alzheimer’s disease in Orange County. In 2012, Dean Frank LaFerla succeeded Professor Cotman as the director of the UCI ADRC and now leads the Administrative Core, which oversees all of the strategic goals and financial aspects of the center. As director, Dean LaFerla has played a major role in recruiting new faculty to the UCI ADRC and establishing a new national core focused on developing induced pluripotent stem (iPS) cells to better study Alzheimer’s disease.
If you’d like to learn more about how you can support the faculty and research at the Biological Sciences School, please contact Andrew DiNuzzo at 949.824.2734 or email@example.com.